RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Supriati Wila Djami
Abstract
This article has been retracted at the request of the Editor in Chief of the Indonesian Journal of Medical Laboratoy Science and Technology (IJMLST) volume 1 number 2 of 2019 pages 65-73 with DOI: 10.33086/ijmlst.v1i2.1159 because it has been published in the Journal of Health Information volume 17 number 1 year 2019 pages 64-74 with DOI: 10.31965/infokes.Vol17.Iss1.232.
Papers submitted to IJMLST should neither published previously nor be under consideration for publication another journal. Therefore, the author should make a statement upon submitting. Reusing data in any form must follow good citation principles, therefore this paper has ethical violations in the scientific publishing system.
Notice of the revocation of "N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) in Stage 1 and Stage 2 Hypertension Patients" in the Indonesian Journal of Medical Laboratoy Science and Technology volume 3 number 1 in 2021.
Downloads
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2019 Supriati Wila Djami
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Rilantono LI. Cardiovascular disease. Jakarta: Faculty of Medicine, University of Indonesia; 2016.
Cardiovascular Specialist Doctors Association of Indonesia (CSDAI). Hypertension Management Guidelines on Cardiovascular Disease. Issue I. Jakarta: Cardiovascular Specialist Doctors Association of Indonesia; 2015.
Joint National Committee (JNC) 8. The Eighth Joint National Committee, Hypertension: The Silent Killer: Update JNC-8 Guideline; 2015.
Muhadi. Evidence-based Guideline. Handling Hypertension Adult Patients, (Online). 2016;43(1).(www.cdkjournal.com/index.php/CDK/article/, Accessed January 14, 2018).
South Sulawesi Provincial Health Office. Health Profile of South Sulawesi Province in 2015. Makassar: South Sulawesi Provincial Health Office; 2015.
Makassar City Health Office. 2015. 2015 Makassar City Health Profile Makassar: Makassar City Health Office.
Hulaima, I.S. 2017. Factors Associated with Control of Blood Pressure in Hypertensive Patients at the Kedaton City Bandar Lampung Health Center. Bandar Lampung: Faculty of Medicine, University of Lampung.
Steffanus M, Wibawa IDN, Nadha IKB. Positive correlation between degree of liver cirrhosis and N terminal-Pro brain natriuretic peptide (NT-pro-BNP).
Khairunnisa. Correlation Levels of NT - proBNP with Left Ventricular Ejection Fraction Function in Children Heart Failure. Padang: Graduate Program in Biomedical Sciences - Medical Specialist Education Program UNAND - RS. M. DJAMIL; 2017.
Bower et al., .N-terminal pro-brain natriuretic peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.American Journal of Hypertension. 2015;28(10):1262-1266.
Hikmah, N. Relationship between Smoking Time and Hypertension in Rannaloe Village, Bungaya District, Gowa Regency. Makassar. Faculty of Medicine and Health UIN Alauddin; 2017.
Azhar I. Hypertension Patient Characteristics picture in Sleman Gamping Puskesmas Yogyakarta. Yogyakarta: College of Health Sciences of the University General Achmad Yani Yogyakarta; 2017.
Sarzani R. et al . NT-proBNP and Its Correlation Hospital Mortality in the Very Elderly without and Admission Diagnosis of Heart Failue.PLOS Journals.2016;11(4): e0153759.
Munir A,Sargowo N. N Terminal Pro Brain Natriuretic Peptide as Indicator of Left Ventricle Hypertropy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography. Jurnal Kardiologi Indonesia. 2010;31(2):87-98.
Asterina F, Nasution B, Akbar N. The Level of N Terminal-Pro Brain Natriuretic Peptide in Hypertensive Heart Disease Patients. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2007;14(1):42–46.